Thrivent Financial for Lutherans’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $649K | Hold |
85,834
| – | – | ﹤0.01% | 2020 |
|
|
2025
Q1 | $474K | Buy |
85,834
+41,732
| +95% | +$230K | ﹤0.01% | 2096 |
|
|
2024
Q4 | $254K | Buy |
+44,102
| New | +$254K | ﹤0.01% | 2447 |
|
|
2024
Q1 | – | Sell |
-10,460
| Closed | -$98K | – | 2538 |
|
|
2023
Q4 | $98K | Sell |
10,460
-527
| -5% | -$4.94K | ﹤0.01% | 2465 |
|
|
2023
Q3 | $123K | Sell |
10,987
-39,570
| -78% | -$443K | ﹤0.01% | 2407 |
|
|
2023
Q2 | $1.08M | Buy |
50,557
+4,517
| +10% | +$96.7K | ﹤0.01% | 1759 |
|
|
2023
Q1 | $1.86M | Buy |
46,040
+26,057
| +130% | +$1.05M | ﹤0.01% | 1344 |
|
|
2022
Q4 | $930K | Sell |
19,983
-155
| -0.8% | -$7.21K | ﹤0.01% | 1772 |
|
|
2022
Q3 | $1.05M | Buy |
20,138
+2,027
| +11% | +$105K | ﹤0.01% | 1657 |
|
|
2022
Q2 | $856K | Buy |
18,111
+3,253
| +22% | +$154K | ﹤0.01% | 1802 |
|
|
2022
Q1 | $1.06M | Buy |
14,858
+216
| +1% | +$15.4K | ﹤0.01% | 1796 |
|
|
2021
Q4 | $1.1M | Buy |
14,642
+99
| +0.7% | +$7.4K | ﹤0.01% | 1798 |
|
|
2021
Q3 | $826K | Sell |
14,543
-150
| -1% | -$8.52K | ﹤0.01% | 1945 |
|
|
2021
Q2 | $647K | Sell |
14,693
-55
| -0.4% | -$2.42K | ﹤0.01% | 2086 |
|
|
2021
Q1 | $727K | Sell |
14,748
-44
| -0.3% | -$2.17K | ﹤0.01% | 2050 |
|
|
2020
Q4 | $623K | Sell |
14,792
-21
| -0.1% | -$884 | ﹤0.01% | 2033 |
|
|
2020
Q3 | $678K | Buy |
14,813
+1,251
| +9% | +$57.3K | ﹤0.01% | 1812 |
|
|
2020
Q2 | $681K | Buy |
13,562
+171
| +1% | +$8.59K | ﹤0.01% | 1749 |
|
|
2020
Q1 | $689K | Buy |
13,391
+668
| +5% | +$34.4K | ﹤0.01% | 1531 |
|
|
2019
Q4 | $786K | Sell |
12,723
-16,794
| -57% | -$1.04M | ﹤0.01% | 1619 |
|
|
2019
Q3 | $1.77M | Buy |
29,517
+17,074
| +137% | +$1.03M | 0.01% | 1068 |
|
|
2019
Q2 | $1.05M | Buy |
12,443
+441
| +4% | +$37.2K | ﹤0.01% | 1367 |
|
|
2019
Q1 | $1.15M | Buy |
12,002
+910
| +8% | +$86.9K | ﹤0.01% | 1284 |
|
|
2018
Q4 | $786K | Buy |
11,092
+243
| +2% | +$17.2K | ﹤0.01% | 1314 |
|
|
2018
Q3 | $927K | Buy |
10,849
+936
| +9% | +$80K | ﹤0.01% | 1320 |
|
|
2018
Q2 | $1.15M | Buy |
9,913
+614
| +7% | +$71.2K | ﹤0.01% | 1178 |
|
|
2018
Q1 | $752K | Buy |
9,299
+393
| +4% | +$31.8K | ﹤0.01% | 1403 |
|
|
2017
Q4 | $523K | Buy |
8,906
+176
| +2% | +$10.3K | ﹤0.01% | 1660 |
|
|
2017
Q3 | $409K | Buy |
8,730
+320
| +4% | +$15K | ﹤0.01% | 1666 |
|
|
2017
Q2 | $303K | Buy |
8,410
+570
| +7% | +$20.5K | ﹤0.01% | 1753 |
|
|
2017
Q1 | $241K | Buy |
7,840
+380
| +5% | +$11.7K | ﹤0.01% | 1800 |
|
|
2016
Q4 | $250K | Buy |
+7,460
| New | +$250K | ﹤0.01% | 1776 |
|
|
2014
Q3 | – | Sell |
-30,731
| Closed | -$1.32M | – | 1867 |
|
|
2014
Q2 | $1.32M | Buy |
+30,731
| New | +$1.32M | 0.01% | 809 |
|